Marinus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	120.57	240.55	122.93	138.51	90.94	67.73	33.53	26.18	51.72	49.72	Upgrade
Short-Term Investments	29.72	0	0	1.47	0.74	5	19.86	3.92	4.47	0	Upgrade
Cash & Cash Equivalents	150.29	240.55	122.93	139.98	91.68	72.73	53.39	30.1	56.2	49.72	Upgrade
Cash Growth	-37.52%	95.69%	-12.18%	52.68%	26.07%	36.21%	77.38%	-46.44%	13.02%	395.37%	Upgrade
Receivables	3.8	6.35	2.63	1.65	0	0	0	0	0	0	Upgrade
Inventory	2.41	0.08	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	8.75	5.4	6.12	4.64	2.45	1.22	0.98	0.2	1.57	0.43	Upgrade
Total Current Assets	165.25	252.38	131.68	146.27	94.13	73.94	54.37	30.3	57.77	50.15	Upgrade
Property, Plant & Equipment	3.84	4.24	2.5	1.95	2.27	1.29	1.34	1.15	0.03	0.04	Upgrade
Long-Term Investments	0	0	0	0	0	0	4.96	0	1.49	0	Upgrade
Other Long-Term Assets	1.82	2.9	2.66	2.25	2.44	0	0	0	0.36	0.02	Upgrade
Total Long-Term Assets	5.66	7.14	5.16	4.2	4.71	1.29	6.3	1.15	1.88	0.07	Upgrade
Total Assets	170.91	259.52	136.84	150.46	98.84	75.23	60.67	31.45	59.65	50.21	Upgrade
Accounts Payable	4	4.46	3.13	2.21	2.76	2.47	0.93	2.81	3.15	0.54	Upgrade
Deferred Revenue	17.55	16.29	0	0	0	0	0	0	0	0	Upgrade
Current Debt	13.76	1.02	0	0	0	0	0	3.5	2.13	0	Upgrade
Other Current Liabilities	5.31	3.25	37.44	8.52	5.27	4.44	1.62	1.78	2.16	1.5	Upgrade
Total Current Liabilities	40.62	25.02	40.57	10.73	8.03	6.91	2.54	8.08	7.44	2.04	Upgrade
Long-Term Debt	95.19	100.88	40.81	0	0	0	0	1.74	5.24	7	Upgrade
Other Long-Term Liabilities	18.33	17.63	1.98	2.53	3.04	0	0.12	0.14	0.06	0.02	Upgrade
Total Long-Term Liabilities	113.52	118.5	42.79	2.53	3.04	0	0.12	1.88	5.29	7.02	Upgrade
Total Liabilities	154.14	143.52	83.35	13.26	11.07	6.91	2.66	9.97	12.73	9.06	Upgrade
Total Debt	108.95	101.9	40.81	0	0	0	0	5.24	7.36	7	Upgrade
Debt Growth	6.92%	149.69%	-	-	-	-	-	-28.80%	5.20%	-	Upgrade
Retained Earnings	-571.93	-430.52	-410.71	-311.93	-235.57	-181.45	-144.73	-125.83	-97.19	-72.34	Upgrade
Comprehensive Income	-0.02	0	0	0	0	-0	-0.1	0	0	0	Upgrade
Shareholders' Equity	16.77	116	53.49	137.2	59.57	68.33	58.01	21.48	46.92	41.15	Upgrade
Net Cash / Debt	41.34	138.66	82.12	139.98	91.68	72.73	53.39	24.86	48.83	42.72	Upgrade
Net Cash / Debt Growth	-70.19%	68.85%	-41.34%	52.68%	26.07%	36.21%	114.80%	-49.10%	14.31%	325.63%	Upgrade
Net Cash Per Share	0.77	3.55	2.24	5.13	6.73	7.11	9.07	5.10	13.09	27.77	Upgrade
Working Capital	124.62	227.36	91.11	135.54	86.1	67.03	51.83	22.22	50.33	48.11	Upgrade
Book Value Per Share	0.31	2.97	1.46	5.03	4.37	6.68	9.86	4.41	12.58	26.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).